Ohta Ken | 論文著者

Asthma and Allergy Center, National Hospital Organization Tokyo National Hospital, Japan

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan

Center for Pulmonary Diseases, National Hospital Organization, Tokyo National Hospital, Japan

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST) of th

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST) of the Committee for Asthma Prevention and Management Guidelines in the Japanese Society of Allergology

Committee on the Safety of Sustained-Release Theophylline and Injectable Methylxanthines (CST), Committee for Asthma Prevention and Management Guidelines in the Japanese Society of Allergology

Department Of Internal Medicine Faculty Of Medicine Teikyo University

Department Of Internal Medicine Teikyo University School Of Medicine

Department of Internal Medicine, Faculty of Medicine, Teikyo University

Department of Internal Medicine, Teikyo University School of Medicine

Department Of Medicine Teikyo University

Department Of Medicine Teikyo University School Of Medicine

Department of Medicine, Teikyo University

Department of Medicine, Teikyo University School of Medicine

Department Of Pulmonary Medicine And Allergology Teikyo University School Of Medicine

Department of Pulmonary Medicine and Allergology, Teikyo University School of Medicine

Department of Respiratory Diseases, National Hospital Organization Tokyo National Hospital

Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine

Division Of Respiratory Medicine Department Of Medicine Teikyo University School Of Medicine

Division of Respiratory Medicine, Department of Medicine, Teikyo University School of Medicine